NantHealth and Allscripts Join Forces to Develop Precision Solutions at Point of Care in This Era of Genomic Medicine
March 02 2015 - 08:01AM
NantHealth and Allscripts (Nasdaq:MDRX) will collaborate on the
development and delivery of cutting-edge, precision medicine
solutions directly to the point of care. The companies will
introduce an integrated, evidence-based, personalized approach to
healthcare solutions that includes actionable clinical data,
enabling physicians to make informed decisions from complex genomic
and proteomic analysis.
"Our goal is to enable physicians to make better, more informed
decisions, provide best-in-class patient care and monitor the
effectiveness and progress of treatment, using real-time clinical
and pan-omic data never before available," said Dr. Patrick
Soon-Shiong, founder and chief executive officer of NantHealth. "We
look forward to working in partnership with the Allscripts team as
the first major Clinical EMR vendor to take a major advancement
towards the interoperability necessary to enable physicians and
patients to stay engaged and active - before, during and after
treatment - and enable the most appropriate, personalized
intervention as early as possible."
Transforming Cancer Care
Research has shown that a physician's ability to make effective,
evidence-based clinical decisions can improve by using specifically
matched cancer protocols and drugs, delivered to the patient based
on the individual's unique DNA, RNA and proteomic profile, and
integrated with the patient's holistic clinical picture. For the
first time, NantHealth and Allscripts can integrate these two
aspects into a unique knowledge-based solution to significantly
improve the way clinicians treat cancer.
Beginning with genomic (DNA) and transcriptome (RNA) sequencing,
foundational data on how a patient is likely to respond to a
specific treatment protocol will integrate with big data and
data-mining-based computational analysis. These new NantHealth
technologies will enable providers to determine the most accurate
treatment option in today's complex world of genomically driven
cancer care.
With this comprehensive view of the patient from all data
sources, physicians can then use NantHealth's eviti solution, a
comprehensive oncology decision support application that helps
select the optimal protocol for patients and verifies their
eligibility for it. The eviti platform empowers oncologists with
real-time, actionable, evidence-based treatment and clinical trial
information to help them make informed treatment decisions for
their patients.
Managing Population Health
NantHealth can gather and monitor patient data via NantHealth's
DeviceConX and Hbox, an industry leading medical device data
integration solution that works at the point of care for clinicians
or at home for the patient. Combined with critical clinical data
from the physician's EMR and community data collected across the
continuum of care, clinicians can proactively manage and monitor
populations of patients over time and optimize their treatment.
Clinicians can then identify all relevant outcomes, improvements
and gaps in care, and make them available within the care
providers' workflow regardless of their environment.
Together, physicians and patients will have the tools to stay
engaged and active and provide necessary intervention as early as
possible. Leveraging innovations in patient engagement, care
coordination and disease management, NantHealth and Allscripts are
creating the first fully comprehensive and integrated platform that
will provide a transformation to the coordination and delivery of
cancer care.
"We're working with NantHealth to create a game-changing
platform for coordinated cancer care," Allscripts Chief Executive
Officer Paul M. Black said. "Integrated patient information – from
the molecular level and from the entire continuum of care – is a
powerful tool to improve health care."
About Allscripts
Allscripts (Nasdaq:MDRX) is a leader in healthcare information
technology solutions that advance clinical, financial and
operational results. Our innovative solutions connect people,
places and data across an Open, Connected Community of Health™.
Connectivity empowers caregivers to make better decisions and
deliver better care for healthier populations. To learn more, visit
www.allscripts.com, Twitter,
YouTube and It Takes A
Community: The Allscripts Blog.
About NANTHEALTH
NantHealth, a member of the NantWorks ecosystem of companies, is
a transformational healthcare IT company converging science and
technology through a single integrated clinical platform, to
provide actionable health information at the point of care, in the
time of need, anywhere, anytime. NantHealth works to transform
clinical delivery with actionable clinical intelligence at the
moment of decision, enabling clinical discovery through real-time
machine learning systems. The company's technology empowers
physicians, patients, payers and researchers to transcend genomics
into the world of proteomics and the traditional barriers of
today's healthcare system. By converging molecular science,
computer science and big data technology the NantHealth Clinical
Operating System (cOS) platform empowers physicians, patients, and
payers to coordinate best care, monitor outcomes and control cost
in real time. This is the first operating system of its kind in
healthcare that is based on supply chain principles and grid
service oriented architecture and integrates the knowledge base
with the delivery system and the payment system, enabling 21st
century coordinated care at a lower cost. For more information
please visit www.nanthealth.com and follow Dr. Soon-Shiong on
Twitter @solvehealthcare.
© 2015 Allscripts Healthcare, LLC and/or its affiliates. All
Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are
trademarks of Allscripts Healthcare, LLC and/or its affiliates. All
other products are trademarks of their respective holders, all
rights reserved. Reference to these products is not intended to
imply affiliation with or sponsorship of Allscripts Healthcare, LLC
and/or its affiliates.
CONTACT: For more information contact:
Investors:
Seth Frank
312-506-1213
seth.frank@allscripts.com
Media:
Concetta DiFranco
312-447-2466
concetta.difranco@allscripts.com
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Mar 2023 to Mar 2024